VenoStent
VenoStent is a Houston-based medical device company specializing in bioengineered vascular supports, notably its SelfWrap product aimed at reducing dialysis access site failures.
Location
VenoStent is headquartered in Houston, Texas, USA. The company operates primarily within the United States and extends its regional influence to America and Canada.
Industry and Sub-Industry
VenoStent operates within the healthcare sector, specifically focusing on the medical devices sub-industry. The company specializes in bioengineered solutions to improve outcomes of vascular surgeries.
Innovative Product: SelfWrap
VenoStent offers SelfWrap, a bioabsorbable, flexible vascular wrap designed to reduce dialysis access site failures. SelfWrap aims to address the high failure rate of dialysis access sites in the first year and is currently in the research and development phase, not yet available for sale.
Clinical Trials and FDA Designation
VenoStent is conducting a 200-subject US clinical trial for SelfWrap. The company has received Breakthrough Device Designation from the FDA and IDE Approval to commence the US trial.
Funding and Team
VenoStent has successfully completed a $16 million Series A Financing. The company leverages a team of 17 experts skilled in biomedical engineering, materials engineering, and medical 3D printing. They are part of the Y-Combinator S20 batch.